Biofrontera Inc.
BFRI
NASDAQ·Healthcare·Medical - Pharmaceuticals·Mkt cap $19.7M
$1.53
▼ -0.26%
P/E
-2.64
Mkt Cap
$19.7M
52-Wk Range
$0.56–$1.61
52-Week Range
$0.56 - $1.61
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 82.7% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- FDA-approved proprietary photodynamic therapy platform
- Integrated drug-device combination products reducing competition
- Specialized focus on underserved dermatological markets
- Established relationships with dermatology practitioners and clinics
Bear Case
1 risk
- Low volatility (beta 0.8).
Growth
Stable outlook
Increased diagnosis and treatment rates for actinic keratosis
Value
Deep value opportunity - significant discount to Large Cap Pharma peers
Momentum
Hot
+49.0% over 3m
Quality
Excellent
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying BFRI right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 11, 2026
AUG 13, 2026
Reported EPS of -$0.05 vs -$0.11 consensus (+52.4% surprise). Revenue of $12.0M vs $9.5M expected (+26.4%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+52.4%
Revenue trend · last 8Q
—
—
+9%
+15%
-22%
+36%
+17%
+33%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$9.0M
$12.6M
$8.6M
$9.0M
$7.0M
$17.1M
$10.1M
$12.0M
Margins · last 8Q
Gross
81.8%
Operating
-4.4%
Profit
-5.0%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Benchmark · May 19, 2026
vs Industry
How BFRI stacks vs Medical - Pharmaceuticals
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related